Home › Funds › Game Creek Capital, LP › REGN
Game Creek Capital, LP position in REGN
REGENERON PHARMACEUTICALS · Health Care
Game Creek Capital, LP reported holding 1,710 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.60% of its reported portfolio and ranking #45 among its reported holdings. Game Creek Capital, LP has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Game Creek Capital, LP's REGN position evolved
Game Creek Capital, LP first disclosed a stake in REGN in Q2 2025 at 3,075 shares (US$1.6M). The position peaked in Q4 2025 at 8,435 shares, worth US$6.5M. Across 6 filings, Game Creek Capital, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,710 shares valued at US$1.3M — an increase of 1,210 shares quarter over quarter.. Notable position changes include a 71% increase in Q4 2025 (shares were roughly flat over the following quarter), a 88% trim in Q1 2026 (shares fell 18% over the following quarter), a 242% increase in Q3 2026 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 3.08K | $1.61M | New |
| Q3 2025 | 4.92K | $2.77M | Add |
| Q4 2025 | 8.44K | $6.51M | Add |
| Q1 2026 | 1.00K | $772.64K | Reduce |
| Q2 2026 | 500 | $311.77K | Reduce |
| Q3 2026 | 1.71K | $1.30M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on Game Creek Capital, LP
FAQ
How long has Game Creek Capital, LP held REGN?
Game Creek Capital, LP has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Game Creek Capital, LP's current position in REGN?
As of Q3 2026, Game Creek Capital, LP holds 1.71K shares of REGN (REGENERON PHARMACEUTICALS), valued at $1.30M, representing 0.60% of its reported portfolio and ranking #45.
Has Game Creek Capital, LP been buying or selling REGN?
In the latest 13F filing (Q3 2026), Game Creek Capital, LP increased its position in REGN. The position peaked in Q4 2025 at 8.44K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.